ACAD - ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc. , a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
As of May 15, 2026: spot at $21.43, ATM IV 42.3%, net GEX -$9.9K.
- Sector
- Healthcare
- Industry
- Biotechnology
- Market Cap
- $3.80B
- P/E Ratio
- 10.07
- Beta
- 0.86
- 52-Week Range
- 16.97-28.35
- CEO
- Catherine E. Owen Adams
- Employees
- 653
- IPO Date
- May 27, 2004
- Exchange
- NASDAQ
What ACAD Looks Like to Options Traders Today
IV rank of 22.6% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); negative net gamma exposure (-$9.9K) means dealers hedge with trend, amplifying realized volatility and accelerating directional moves; the 25-delta skew (0.060) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The ACAD overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked ACAD overview questions
- What is ACAD?
- ACAD is the ticker symbol for ACADIA Pharmaceuticals Inc., a listed security. ACADIA Pharmaceuticals Inc. , a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Listed on NASDAQ. ACAD is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the ACAD options snapshot look like today?
- As of May 15, 2026, the ACAD options snapshot shows spot at $21.43, ATM IV 42.3%, IV rank 22.6%, net GEX -$9.9K, expected move 12.13%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are ACAD's key statistics?
- ACADIA Pharmaceuticals Inc. (ACAD) carries a market capitalization of $3.80B, trailing P/E ratio of 10.07, beta of 0.86 relative to the broader market, 52-week range of 16.97-28.35. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does ACAD belong to?
- ACADIA Pharmaceuticals Inc. operates in the Healthcare sector, in the Biotechnology industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare ACAD's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the ACAD data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).